We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Bladder Cancer

Journal Scan / Research · December 28, 2022

Effect of APOBEC3G on Mutagenesis and Clonal Evolution in Bladder Cancer

Cancer Research


Additional Info

Cancer Research
The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer
Cancer Res 2022 Dec 08;[EPub Ahead of Print], W Liu, KP Newhall, F Khani, L Barlow, D Nguyen, L Gu, K Eng, B Bhinder, M Uppal, C Récapet, A Sboner, SR Ross, O Elemento, L Chelico, BM Faltas

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading